Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › Walter Parazaider, founding member of Chicago, dies aged 81
Health

Walter Parazaider, founding member of Chicago, dies aged 81

The Guardian World Wednesday 17 June 2026, 18:34 UTC By Owen Myers 1 min read
Key Points

The originating member of the band with hits like If You Leave Me Now and Hard to Say I’m Sorry died after a battle with Alzheimer’s diseaseWalter Parazaider, a co-founding member of the rock band Chicago, has died at the age of 81 following a battle with Alzheimer’s disease. His daughter confirmed the news in a Facebook post on Wednesday morning.

The originating member of the band with hits like If You Leave Me Now and Hard to Say I’m Sorry died after a battle with Alzheimer’s disease

Walter Parazaider, a co-founding member of the rock band Chicago, has died at the age of 81 following a battle with Alzheimer’s disease.

His daughter confirmed the news in a Facebook post on Wednesday morning.

Continue reading...
Walter Parazaider (PERSON) Chicago (LOCATION) Parazaider (ORG) Facebook (ORG)
Originally published by The Guardian World Read original →

Related Stories

New Plan Scales Back C.D.C.’s Work on Diseases Abroad

Demonstrators in Washington in 2025 protest the withholding of funding from the President’s Emergency Plan for AIDS Relief, PEPFAR.

NYT World 26m ago

New Plan Scales Back C.D.C.’s Work on Diseases Abroad

Demonstrators in Washington in 2025 protest the withholding of funding from the President’s Emergency Plan for AIDS Relief, PEPFAR.

NYT Science 26m ago

Olympic runner Simpson collapses at track event

RALEIGH, N.C. -- Olympic bronze medalist and world-champion 1,500-meter runner Jenny Simpson collapsed after suffering a medical episode while pacing a mile group at an event in Raleigh, North Carolina, on Tuesday night. Simpson underwent CPR at the track and an automated external defibrillator was also used before she was taken to the hospital. LetsRun was the first to report the medical emergency.

ESPN 31m ago

J&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says

Jun 17th, 2026 J&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many of its rivals that are trying to develop or acquire obesity medicines following blockbuster weight-loss drugs from Eli Lilly & Co. and Novo...

Bloomberg Markets 32m ago